ACSS3
Acyl-CoA synthetase short-chain family member 3, mitochondrial
Also known as: ACSS3_HUMAN, FLJ21963
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6R3
- Gene
- ACSS3
- Ensembl
- ENSG00000111058
- Chromosome
- 12
- Canonical length
- 686 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Enables propionate-CoA ligase activity. Predicted to be involved in ketone body biosynthetic process. Located in mitochondrial matrix. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>Q9H6R3|ACSS3
1 MKPSWLQCRK VTSAGGLGGP LPGSSPARGA GAALRALVVP GPRGGLGGRG CRALSSGSGS
61 EYKTHFAASV TDPERFWGKA AEQISWYKPW TKTLENKHSP STRWFVEGML NICYNAVDRH
121 IENGKGDKIA IIYDSPVTNT KATFTYKEVL EQVSKLAGVL VKHGIKKGDT VVIYMPMIPQ
181 AMYTMLACAR IGAIHSLIFG GFASKELSSR IDHVKPKVVV TASFGIEPGR RVEYVPLVEE
241 ALKIGQHKPD KILIYNRPNM EAVPLAPGRD LDWDEEMAKA QSHDCVPVLS EHPLYILYTS
301 GTTGLPKGVI RPTGGYAVML HWSMSSIYGL QPGEVWWAAS DLGWVVGHSY ICYGPLLHGN
361 TTVLYEGKPV GTPDAGAYFR VLAEHGVAAL FTAPTAIRAI RQQDPGAALG KQYSLTRFKT
421 LFVAGERCDV ETLEWSKNVF RVPVLDHWWQ TETGSPITAS CVGLGNSKTP PPGQAGKSVP
481 GYNVMILDDN MQKLKARCLG NIVVKLPLPP GAFSGLWKNQ EAFKHLYFEK FPGYYDTMDA
541 GYMDEEGYLY VMSRVDDVIN VAGHRISAGA IEESILSHGT VADCAVVGKE DPLKGHVPLA
601 LCVLRKDINA TEEQVLEEIV KHVRQNIGPV AAFRNAVFVK QLPKTRSGKI PRSALSAIVN
661 GKPYKITSTI EDPSIFGHVE EMLKQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACSS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- liver: 37 nTPM
- kidney: 24 nTPM
- adipose tissue: 21 nTPM
- ovary: 17 nTPM
- adrenal gland: 14 nTPM
- parathyroid gland: 13 nTPM
Single-cell type
- adipocytes: 468 nCPM
- cardiomyocytes: 304 nCPM
- myonuclei: 270 nCPM
- astrocytes: 266 nCPM
- ependymal cells: 245 nCPM
- pituitary stem cells: 239 nCPM
Immune cell
- basophil: 7.1 nTPM
- neutrophil: 2.2 nTPM
- eosinophil: 0.3 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 19 nTPM
- thalamus: 13 nTPM
- midbrain: 13 nTPM
- medulla oblongata: 11 nTPM
- white matter: 11 nTPM
- cerebellum: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- acetate-CoA ligase activity
- ATP binding
- medium-chain fatty acid-CoA ligase activity
- propionate-CoA ligase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AMP-dependent synthetase/ligase domain
- AMP-binding, conserved site
- AMP-binding enzyme, C-terminal domain
- Acetyl-coenzyme A synthetase, N-terminal domain
- ANL, N-terminal domain
- AMP-binding enzyme domain superfamily
- AMP-binding enzyme
- AMP-binding enzyme C-terminal domain
- Acetyl-coenzyme A synthetase N-terminus
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACSS3 as an antibody target. Whether an autoantibody or antibody against ACSS3 could matter depends on whether native ACSS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACSS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACSS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...